Regulatory T Cells Exhibit Interleukin-33-Dependent Migratory Behavior during Skin Barrier Disruption.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Jul 2021
Historique:
received: 09 06 2021
revised: 07 07 2021
accepted: 07 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 31 7 2021
Statut: epublish

Résumé

Regulatory T cells (Tregs) suppress immune responses and maintain immunological self-tolerance and homeostasis. We currently investigated relationships between skin barrier condition and Treg behavior using skin barrier-disrupted mice. Skin barrier disruption was induced by repeated topical application of 4% sodium dodecyl sulfate (SDS) on mice. The number of CD4

Identifiants

pubmed: 34299063
pii: ijms22147443
doi: 10.3390/ijms22147443
pmc: PMC8304226
pii:
doi:

Substances chimiques

Forkhead Transcription Factors 0
Foxp3 protein, mouse 0
Il33 protein, mouse 0
Interleukin-33 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Grant-in-Aid for Research Activity Start-up
ID : 17H07096
Organisme : 19K17817
ID : Grant-in-Aid for Early-Career Scientists

Références

Nat Immunol. 2003 Apr;4(4):337-42
pubmed: 12612581
J Immunol. 1999 Nov 15;163(10):5211-8
pubmed: 10553041
Annu Rev Immunol. 2016 May 20;34:609-33
pubmed: 27168246
J Allergy Clin Immunol. 2006 Jan;117(1):176-83
pubmed: 16387603
J Invest Dermatol. 2009 Aug;129(8):1892-908
pubmed: 19494826
Nat Genet. 2001 Jan;27(1):68-73
pubmed: 11138001
Nat Immunol. 2017 Oct;18(10):1160-1172
pubmed: 28783152
J Immunol. 2014 Jan 15;192(2):817-23
pubmed: 24337379
J Dermatol Sci. 2012 Apr;66(1):37-43
pubmed: 22381253
Immunity. 2019 Apr 16;50(4):924-940
pubmed: 30995507
Immunity. 2015 May 19;42(5):903-15
pubmed: 25979421
Curr Probl Dermatol. 2016;49:47-60
pubmed: 26844897
Immunity. 2008 Apr;28(4):546-58
pubmed: 18387831
Eur J Immunol. 2019 Aug;49(8):1140-1146
pubmed: 31257581
J Allergy Clin Immunol. 2008 Dec;122(6):1105-1112.e1
pubmed: 18951619
J Appl Toxicol. 2018 Feb;38(2):274-283
pubmed: 28949055
Nat Immunol. 2005 Apr;6(4):345-52
pubmed: 15785760
Nat Immunol. 2003 Apr;4(4):330-6
pubmed: 12612578
J Invest Dermatol. 2018 Mar;138(3):570-579
pubmed: 29045819
J Clin Invest. 2014 Mar;124(3):1027-36
pubmed: 24509084
Nat Genet. 2001 Jan;27(1):18-20
pubmed: 11137992
J Med Genet. 2002 Aug;39(8):537-45
pubmed: 12161590
J Invest Dermatol. 2015 Jun;135(6):1574-1580
pubmed: 25634358
Dermatol Ther. 2004;17 Suppl 1:43-8
pubmed: 14728698
Eur J Dermatol. 2015 Sep-Oct;25(5):424-35
pubmed: 26109150
Exp Dermatol. 2021 Jun;30(6):811-819
pubmed: 33394542
J Immunol. 1995 Aug 1;155(3):1151-64
pubmed: 7636184
Immunity. 2015 Jul 21;43(1):175-86
pubmed: 26200013
Immunity. 2008 Nov 14;29(5):771-81
pubmed: 18993084
J Mol Diagn. 2012 Jan;14(1):22-9
pubmed: 22166544
Allergy. 2017 Aug;72(8):1148-1155
pubmed: 28160290
Immunity. 2005 Nov;23(5):479-90
pubmed: 16286016
Iran J Immunol. 2019 Jun;16(2):97-107
pubmed: 31182684
Br J Dermatol. 2015 Apr;172(4):940-50
pubmed: 25376752

Auteurs

Sumika Toyama (S)

Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.

Catharina Sagita Moniaga (CS)

Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.

Susumu Nakae (S)

Graduate School of Integrated Sciences for Life, Hiroshima University, 1-4-4 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8528, Japan.

Masaru Kurosawa (M)

Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.

Hideoki Ogawa (H)

Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.

Mitsutoshi Tominaga (M)

Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.

Kenji Takamori (K)

Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.
Department of Dermatology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba 279-0021, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH